米国の照射装置市場規模、シェア、動向分析レポート：タイプ別、用途別、最終用途別、セグメント別予測、2025～2030年

米国の照射装置市場規模・動向

米国の照射装置市場規模は2024年に28億8,000万米ドルと推定され、2025～2030年にかけてCAGR 6.0%で成長すると予測されています。

非侵襲的な医療処置に対する需要の高まりが、照射装置市場成長の大きな原動力となっています。患者や医療プロバイダーが従来の侵襲的な方法に代わる方法を求める中、精密な滅菌や機器を必要とすることが多い非侵襲的な処置が人気を集めています。さらに、核医療における診断・治療用途での照射装置の使用増加が市場成長をさらに後押ししています。

がん、心血管疾患、筋骨格系障害、前立腺がん、乳がんなどの慢性疾患の罹患率の増加は、非侵襲的診断ソリューションの採用の重要な促進要因です。これらの疾患には先進的画像診断技術が必要であり、X線などの照射装置が広く使用されています。こうした装置は早期かつ正確な診断を可能にし、侵襲的な処置を必要としないタイムリーな介入と治療を可能にします。さらに、米国のがん患者数は2022年に190万人に達しました。米国がん協会によると、肺がんは最も多く診断されるがんの一つであり、2024年だけでも米国では23万4,580人以上の新規症例が予想されています。さらに、米国における2022年の前立腺がんの発生率と罹患率は23万125人です。この動向は患者の転帰を向上させ、患者の安全性と有効性を優先する非侵襲的アプローチへの医療部門内の広範なシフトを反映しています。

核医療の範囲が拡大したことで、医療用画像診断と治療の高精度を保証する照射装置の需要が高まっています。この動向は、米国の医療サービスの能力向上における照射装置の重要な役割を強調しています。低分割放射線治療の利用は、米国の照射装置市場の顕著な成長に寄与しています。より少ない回数でより高線量の放射線を照射するこの治療法は、患者のアドヒアランスと治療成績を向上させ、同時に全体的な医療コストを削減します。このアプローチは現在の機器の使用を最適化し、既存の放射線治療システムをより効率的なものにします。さらに、画像誘導放射線治療（IGRT）や強度変調放射線治療（IMRT）のような、正確で効果的な治療を行うために不可欠な先進技術に対する需要も促進しています。その結果、こうした進歩や治療の革新が米国の照射装置市場の成長を牽引しています。

さらに、強度変調放射線治療、画像誘導放射線治療、定位体放射線治療などの放射線治療における技術革新は、がん治療を強化しています。この動向は、罹患した腫瘍への放射線量を増やすと同時に、健康な組織への影響を軽減するのに役立っています。例えば、2024年6月、Thermo Fisher Scientificは、放射線被曝線量の測定における安全性と正確性を高めるために設計された放射線量計NetDose PROを発売しました。この線量計はNVLAP（National Voluntary Laboratory Accreditation Program）の認定を受けており、高い安全基準を満たしています。NetDose PROは、医療や調査など様々な環境における放射線モニタリングの向上を目指しています。Thermo Fisher ScientificのNetDose PRO放射線量計の発売は、放射線安全技術の進歩を浮き彫りにするものであり、照射装置を利用する環境にとって極めて重要です。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 米国の照射装置市場の変数、動向、範囲

• 市場系統の展望
  • 親市場の展望
  • 関連/付随市場の展望
• 浸透と成長の見込みマッピング
• 産業バリューチェーン分析
  • 償還枠組み
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 米国の照射装置市場分析ツール
  • 産業分析-ポーターのファイブフォース分析
  • PESTEL分析

第4章 米国の照射装置市場：タイプ別、推定・動向分析

• セグメントダッシュボード
• 米国の照射装置市場変動分析
• 世界の米国照射装置市場規模と動向分析、タイプ別、2018～2030年
• X線検査
• ガンマ線
• 高速中性子
• 電子
• アルファベータ粒子

第5章 米国の照射装置市場：用途別、推定・動向分析

• セグメントダッシュボード
• 米国における世界照射装置の用途市場変動分析
• 世界の米国照射装置市場規模と動向分析、用途別、2018～2030年
• 診断
  • 診断、推定・予測、2018～2030年
• 治療
  • 治療、推定・予測、2018～2030年
• 歯科
  • 歯科、推定・予測、2018～2030年
• その他
  • その他、推定・予測、2018～2030年

第6章 米国の照射装置市場：最終用途別、推定・動向分析

• セグメントダッシュボード
• 米国における照射装置の最終用途市場変動分析
• 世界の米国照射装置市場規模と動向分析、最終用途別、2018～2030年
• 病院
  • 病院、推定・予測、2018～2030年
• ラボ
• その他

第7章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業/競合の分類
• 主要企業の市場シェア分析、2024年
• Company Position Analysis
• 企業分類（新興企業、イノベーター、リーダー）
• 企業プロファイル
  • Siemens Healthineers（Varian Medical Systems, Inc.）
  • Elekta
  • GE HealthCare
  • Accuray Incorporated
  • IBA Radiopharma Solutions
  • Koninklijke Philips NV
  • Nordion（カナダ）Inc.
  • STERIS
  • Precision X-Ray
  • Carestream Dental LLC.

List of Tables

• Table 1 List of Abbreviation
• Table 2 U.S. irradiation apparatus market, by type, 2018 - 2030 (USD Million)
• Table 3 U.S. irradiation apparatus market, by application, 2018 - 2030 (USD Million)
• Table 4 U.S. irradiation apparatus market, by end use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value-chain-based sizing & forecasting
• Fig. 6 QFD modeling for market share assessment
• Fig. 7 Market formulation & validation
• Fig. 8 U.S. irradiation apparatus market: market outlook
• Fig. 9 U.S. irradiation apparatus market competitive insights
• Fig. 10 Parent market outlook
• Fig. 11 Related/ancillary market outlook
• Fig. 12 Penetration and growth prospect mapping
• Fig. 13 Industry value chain analysis
• Fig. 14 U.S. irradiation apparatus market Driver Impact
• Fig. 15 U.S. irradiation apparatus market Restraint Impact
• Fig. 16 U.S. irradiation apparatus market Strategic Initiatives Analysis
• Fig. 17 U.S. irradiation apparatus market: Type Movement Analysis
• Fig. 18 U.S. irradiation apparatus market: Type outlook and key takeaways
• Fig. 19 Gamma rays market estimates and forecast, 2018 - 2030
• Fig. 20 X-rays market estimates and forecast, 2018 - 2030
• Fig. 21 High-speed neutrons market estimates and forecast, 2018 - 2030
• Fig. 22 Electrons market estimates and forecast, 2018 - 2030
• Fig. 23 Alpha-beta particles market estimates and forecast, 2018 - 2030
• Fig. 24 Others market estimates and forecast, 2018 - 2030
• Fig. 25 U.S. irradiation apparatus market: Application Movement Analysis
• Fig. 26 U.S. irradiation apparatus market: Application outlook and key takeaways
• Fig. 27 Diagnostic market estimates and forecast, 2018 - 2030
• Fig. 28 Therapeutic market estimates and forecast, 2018 - 2030
• Fig. 29 Dental market estimates and forecast, 2018 - 2030
• Fig. 30 Others market estimates and forecast, 2018 - 2030
• Fig. 31 U.S. irradiation apparatus market: End use Movement Analysis
• Fig. 32 U.S. irradiation apparatus market: End use outlook and key takeaways
• Fig. 33 Hospitals market estimates and forecast, 2018 - 2030
• Fig. 34 Diagnostic imaging centers estimate and forecast, 2018 - 2030
• Fig. 35 Others estimate and forecast, 2018 - 2030
• Fig. 36 Participant Categorization- U.S. irradiation apparatus market
• Fig. 37 Market share of key market players- U.S. irradiation apparatus market

U.S. Irradiation Apparatus Market Size & Trends:

The U.S. irradiation apparatus market size was estimated at USD 2.88 billion in 2024 and is expected to grow at a CAGR of 6.0% from 2025 to 2030. The increasing demand for non-invasive medical procedures is a significant driving factor in the growth of the irradiation apparatus market. As patients and healthcare providers seek alternatives to traditional invasive methods, non-invasive procedures, which often require precise sterilization and equipment, are gaining popularity. Furthermore, the increased usage of irradiation devices in nuclear medicine for diagnostic and therapeutic applications further propels market growth.

The increasing incidence of chronic diseases such as cancer, cardiovascular diseases, musculoskeletal disorders, prostate cancer, and breast cancer is a significant driver for the adoption of non-invasive diagnostic solutions. These conditions necessitate sophisticated imaging techniques, where X-ray and other irradiation apparatus are widely used. Such devices enable early and accurate diagnosis, allowing timely intervention and treatment that does not require invasive procedures. Furthermore, the number of cancer cases in the U.S. reached 1.9 million in 2022. According to the American Cancer Society, lung cancer is one of the most diagnosed cancers, with over 234,580 new cases expected in the U.S. in 2024 alone. Furthermore, the incidence and rate of prostate cancer in 2022 in the U.S. were 230,125. This trend enhances patient outcomes and reflects a broader shift within the healthcare sector toward non-invasive approaches that prioritize patient safety and efficacy.

The expanding scope of nuclear medicine has driven the demand for irradiation equipment that ensures high precision in medical imaging and treatment delivery. This trend underscores the critical role of irradiation apparatus in enhancing the capabilities of healthcare services in the U.S. The usage of hypo-fractionated radiotherapy contributes to notable growth in the U.S. market for irradiation apparatus. This treatment method, which delivers higher doses of radiation over fewer sessions, improves patient adherence and treatment outcomes while reducing overall healthcare costs. This approach optimizes the use of current equipment, making existing radiotherapy systems more efficient. Furthermore, it fuels demand for advanced technologies such as Image-Guided Radiation Therapy (IGRT) and Intensity-Modulated Radiation Therapy (IMRT), essential for delivering precise and effective treatment. Consequently, these advancements and treatment innovations drive market growth for irradiation apparatus in the U.S.

Furthermore, technological innovations in radiation therapies, such as intensity-modulated radiation therapy, image-guided radiation therapy, and stereotactic body radiotherapy, have enhanced cancer treatments. The trend helps to increase the radiation dose to affected tumors and, simultaneously, reduce the effects on the healthy tissues. For instance, In June 2024, Thermo Fisher Scientific launched the NetDose PRO radiation dosimeter, designed to enhance safety and accuracy in measuring radiation exposure. This device is accredited by the National Voluntary Laboratory Accreditation Program (NVLAP), ensuring it meets high safety standards. The NetDose PRO aims to improve radiation monitoring in various settings, including healthcare and research environments. The launch of Thermo Fisher Scientific's NetDose PRO radiation dosimeter highlights advancements in radiation safety technology, which is crucial for environments utilizing irradiation devices.

U.S. Irradiation Apparatus Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. irradiation apparatus market report based on type, application, and end-use:

• Type Outlook (Revenue, USD Billion, 2018 - 2030)
• Gamma Rays
• X-rays
• High-speed Neutrons
• Electrons
• Alpha-beta Particles
• Others
• Type Outlook (Revenue, USD Billion, 2018 - 2030)
• Diagnostic
• Therapeutic
• Dental
• Others
• End-use Outlook (Revenue, USD Billion, 2018 - 2030)
• Hospitals
• Laboratories
• Other End Users

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Type
  • 1.1.2. Application
  • 1.1.3. End use
  • 1.1.4. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives
  • 1.9.1. Objective 1
  • 1.9.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. Application
  • 2.2.3. End use outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Irradiation Apparatus Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Industry Value Chain Analysis
  • 3.3.1. Reimbursement framework
• 3.4. Market Dynamics
  • 3.4.1. Market driver analysis
    • 3.4.1.1. Increasing demand for non-invasive medical procedures
    • 3.4.1.2. Increased usage of irradiation devices in nuclear medicine for diagnostic and therapeutic operations
    • 3.4.1.3. Technological advancements in irradiation equipment
  • 3.4.2. Market restraint analysis
    • 3.4.2.1. High initial costs and maintenance expenses
    • 3.4.2.2. Radiation safety concerns and potential health risks
• 3.5. U.S. Irradiation Apparatus Market Analysis Tools
  • 3.5.1. Industry Analysis - Porter's
    • 3.5.1.1. Supplier power
    • 3.5.1.2. Buyer power
    • 3.5.1.3. Substitution threat
    • 3.5.1.4. Threat of new entrant
    • 3.5.1.5. Competitive rivalry
  • 3.5.2. PESTEL Analysis
    • 3.5.2.1. Political landscape
    • 3.5.2.2. Technological landscape
    • 3.5.2.3. Economic landscape

Chapter 4. U.S. Irradiation Apparatus Market: Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global U.S. Irradiation Apparatus Type Market Movement Analysis
• 4.3. Global U.S. Irradiation Apparatus Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
• 4.4. X-rays
  • 4.4.1. X-rays market estimates and forecast 2018 - 2030 (USD Million)
• 4.5. Gamma Rays
  • 4.5.1. Gamma rays market estimates and forecast 2018 - 2030 (USD Million)
• 4.6. High-speed Neutrons
  • 4.6.1. High-speed neutrons market estimates and forecast 2018 - 2030 (USD Million)
• 4.7. Electrons
  • 4.7.1. Electrons market estimates and forecast 2018 - 2030 (USD Million)
• 4.8. Alpha-beta Particles
  • 4.8.1. Alpha-beta Particles market estimates and forecast 2018 - 2030 (USD Million)

Chapter 5. U.S. Irradiation Apparatus Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global U.S. Irradiation Apparatus Application Market Movement Analysis
• 5.3. Global U.S. Irradiation Apparatus Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. Diagnostic
  • 5.4.1. Diagnostic estimates and forecast 2018 - 2030 (USD Million)
• 5.5. Therapeutic
  • 5.5.1. Therapeutic estimates and forecast 2018 - 2030 (USD Million)
• 5.6. Dental
  • 5.6.1. Dental estimates and forecast 2018 - 2030 (USD Million)
• 5.7. Others
  • 5.7.1. Others estimates and forecast 2018 - 2030 (USD Million)

Chapter 6. U.S. Irradiation Apparatus Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global U.S. Irradiation Apparatus End Use Market Movement Analysis
• 6.3. Global U.S. Irradiation Apparatus Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 6.4. Hospitals
  • 6.4.1. Hospitals estimates and forecast 2018 - 2030 (USD Million)
• 6.5. Laboratories
  • 6.5.1. Laboratories market estimates and forecast 2018 - 2030 (USD Million)
• 6.6. Others
  • 6.6.1. Others market estimates and forecast 2018 - 2030 (USD million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
• 7.3. Key company market share analysis, 2024
• 7.4. Company Position Analysis
• 7.5. Company Categorization (Emerging Players, Innovators and Leaders
• 7.6. Company Profiles
  • 7.6.1. Siemens Healthineers (Varian Medical Systems, Inc.)
    • 7.6.1.1. Company overview
    • 7.6.1.2. Financial performance
    • 7.6.1.3. Product benchmarking
    • 7.6.1.4. Strategic initiatives
  • 7.6.2. Elekta
    • 7.6.2.1. Company overview
    • 7.6.2.2. Financial performance
    • 7.6.2.3. Product benchmarking
    • 7.6.2.4. Strategic initiatives
  • 7.6.3. GE HealthCare
    • 7.6.3.1. Company overview
    • 7.6.3.2. Financial performance
    • 7.6.3.3. Product benchmarking
    • 7.6.3.4. Strategic initiatives
  • 7.6.4. Accuray Incorporated
    • 7.6.4.1. Company overview
    • 7.6.4.2. Financial performance
    • 7.6.4.3. Product benchmarking
    • 7.6.4.4. Strategic initiatives
  • 7.6.5. IBA Radiopharma Solutions
    • 7.6.5.1. Company overview
    • 7.6.5.2. Financial performance
    • 7.6.5.3. Product benchmarking
    • 7.6.5.4. Strategic initiatives
  • 7.6.6. Koninklijke Philips N.V.
    • 7.6.6.1. Company overview
    • 7.6.6.2. Financial performance
    • 7.6.6.3. Product benchmarking
    • 7.6.6.4. Strategic initiatives
  • 7.6.7. Nordion (Canada) Inc.
    • 7.6.7.1. Company overview
    • 7.6.7.2. Financial performance
    • 7.6.7.3. Product benchmarking
    • 7.6.7.4. Strategic initiatives
  • 7.6.8. STERIS
    • 7.6.8.1. Company overview
    • 7.6.8.2. Financial performance
    • 7.6.8.3. Product benchmarking
    • 7.6.8.4. Strategic initiatives
  • 7.6.9. Precision X-Ray
    • 7.6.9.1. Company overview
    • 7.6.9.2. Financial performance
    • 7.6.9.3. Product benchmarking
    • 7.6.9.4. Strategic initiatives
  • 7.6.10. Carestream Dental LLC.
    • 7.6.10.1. Company overview
    • 7.6.10.2. Financial performance
    • 7.6.10.3. Product benchmarking
    • 7.6.10.4. Strategic initiatives